Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „individual“
Suchtreffer
Begriffe & Kennungen
Abrysvo · 4.8 · Immunocompromised individuals 18 years of age and older Reactogenicity was consistent with the known profile o
Eintrag öffnenAbrysvo · 4.8 · The safety of administering a single dose of Abrysvo to pregnant individuals at 24-36 weeks of gestation and i
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Additional information on the individual components
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · Adverse reactions previously reported with one of the individual components (amlodipine or valsartan) may be p
Eintrag öffnenApixaban Accord · 4.5 · Despite these findings, there may be individuals with a more pronounced pharmacodynamic response when antiplat
Eintrag öffnenApixaban Accord · 4.5 · Despite these findings, there may be individuals with a more pronounced pharmacodynamic response when antiplat
Eintrag öffnenArexvy · 4.8 · Immunocompromised individuals
Eintrag öffnenArexvy · 4.8 · In a US post-marketing observational study in individuals aged 65 years and older, an increased risk of Guilla
Eintrag öffnenAvonex · 4.8 · Patient-time is the sum of individual units of time that the patient in the study has been exposed to AVONEX b
Eintrag öffnenAvonex · 4.8 · Patient-time is the sum of individual units of time that the patient in the study has been exposed to AVONEX b
Eintrag öffnenBiktarvy · 4.5 · Interactions between Biktarvy or its individual component(s) and co-administered medicinal products are listed
Eintrag öffnenBiktarvy · 4.5 · Table 1: Interactions between Biktarvy or its individual component(s) and other medicinal products
Eintrag öffnenBimervax · 4.8 · 5 Table 1: Adverse reactions from BIMERVAX clinical trials in individuals 12 years of age and older
Eintrag öffnenBimervax · 4.8 · Individuals 18 years of age and older The most common adverse reactions reported after a booster dose with BIM
Eintrag öffnenBimervax · 4.8 · Individuals 18 years of age and older The most common adverse reactions reported after a booster dose with BIM
Eintrag öffnenBimervax · 4.8 · Individuals 18 years of age and older The most common adverse reactions reported after a booster dose with BIM
Eintrag öffnenBimervax · 4.8 · Individuals 18 years of age and older The most common adverse reactions reported after a booster dose with BIM
Eintrag öffnenBimervax · 4.8 · Table 1: Adverse reactions from BIMERVAX clinical trials in individuals 12 years of age and older
Eintrag öffnenBimervax · 4.8 · Table 1: Adverse reactions from BIMERVAX clinical trials in individuals 12 years of age and older
Eintrag öffnenBimervax · 4.8 · Table 1: Adverse reactions from BIMERVAX clinical trials in individuals 12 years of age and older
Eintrag öffnen